Ignite Creation Date:
2025-12-25 @ 2:06 AM
Ignite Modification Date:
2026-05-19 @ 8:01 AM
Study NCT ID:
NCT01235260
Status:
COMPLETED
Last Update Posted:
2016-07-19
First Post:
2010-11-04
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Becaplermin Use and Cancer Risk in a Patient Population of U.S. Veterans With Diabetes
Sponsor:
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CR017497
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | OTHER | View |